World Health Organization warns of untreatable superbug gonorrhoea found in at least 3 patients

Gonorrhea Resistance on the Rise

Gonorrhea Resistance on the Rise

Nowadays, gonorrhoea needs to be treated with both an antibiotic injection and a dose of antibiotic tablets.

This is because the infection is rapidly developing a resistance to antibiotics.

Untreated infection can lead to infertility, pelvic inflammatory disease and can be passed on to a child during pregnancy.

The Centers for Disease Control and Prevention (CDC) in the US estimates that more than 800,000 new cases of gonorrhea occur each year. It also often spreads silently.

It can infect the genitals, throat and rectum and the World Health Organization said over-use of antibiotics is to blame.

Symptoms of gonorrhea can include burning and discolored discharge, but, according to the Centers for Disease Control and Prevention, most women with gonorrhea don't experience any symptoms, or have symptoms that are so mild that they may be mistaken for a vaginal or bladder infection.

Treatment involves an antibiotic injection and a single dose of antibiotic tablets.

Several cases of difficult-to-treat gonorrhea have been reported in the US, including a cluster of seven cases seen previous year in Hawaii.

Where did the study come from?

What is the new evidence?


Data from 77 countries show that antibiotic resistance is making the common sexually-transmitted infection as incurable as it was in the 1920s, before the first drugs to treat it were discovered.

Earlier this year, World Health Organization announced that it is classifying antibiotics into three categories - Access, Watch and Reserve - to preserve the effectiveness of "last resort" antibiotics. Officials are anxious most about the last one. But with the growing resistance to commonly used antibiotics by so many bacterial strains, it has become an nearly emergency situation that needs to be addressed.

That tendency is exacerbated by other, outside factors, including incorrect use or overuse of common antibiotics and use of poor quality antibiotics, said Wi, the medical officer of the WHO's Department of Reproductive Health and Research.

GARDP is a not-for-profit research organisation that sets up programmes around the world that aim to develop short- and long-term treatments for STIs, among other things.

With few new treatment options on the horizon, health experts say the outlook is "fairly grim".

GARDP seeks to work with various experts to bring one new treatment for gonorrhoea to the market by 2023.

But there are only three new potential medicines in development, and there's no guarantee that any will prove effective in final-stage trials, according to the report.

For the diagnosis of gonorrhea, no affordable, rapid and point-of-care tests are available. 97 percent of the countries it monitors for trends in drug-resistant gonorrhea reported widespread resistance to the antibiotic ciprofloxacin; 81 percent reported resistance to the drug azithromycin; and 66 percent reported the emergence of resistance to last-resort treatment.

An estimated 78 million people are diagnosed with gonorrhea every year around the globe.

The WHO and Kularatne called for new antibiotics‚ better detection and better tests to find where the patients have no symptoms‚ as well as better global monitoring efforts.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.